Bioatla, INC Form 4 insider transactions

Eric Sievers, Chief Medical Officer of BioAtla, Inc., reports a transaction involving the withholding of shares by the issuer to cover income tax obligations related to vesting restricted stock units.

Richard Waldron, CFO of BioAtla, Inc., reports the withholding of shares to cover income tax obligations related to vesting restricted stock units.

Christian Vasquez, Chief Accounting Officer, Corporate Controller, and Secretary of BioAtla, Inc., reports the withholding of shares to cover income tax obligations related to vested restricted stock units.

Director Scott Andrew Smith reports a transaction involving the withholding of BioAtla shares to cover income tax obligations related to vesting restricted stock units.

Eric Sievers, Chief Medical Officer of BioAtla, Inc., reports a transaction involving the withholding of shares by the issuer to cover income tax obligations related to vesting restricted stock units.

Director Scott Andrew Smith reports a transaction involving the withholding of BioAtla shares to cover tax obligations related to vested restricted stock units.

Eric Sievers, Chief Medical Officer of BioAtla, Inc., reports changes in beneficial ownership due to shares withheld by the issuer to cover tax obligations related to vesting restricted stock units.

Director Scott Andrew Smith reports a transaction involving the withholding of BioAtla shares to cover income tax obligations related to vesting restricted stock units.

Eric Sievers, Chief Medical Officer of BioAtla, Inc., reports a transaction involving the withholding of shares by the issuer to cover income tax obligations related to vesting restricted stock units.

Director Mary Ann Gray acquired 16,500 shares of BioAtla, Inc. common stock through a restricted stock unit award.

BioAtla Director Sylvia McBrinn reports the acquisition of 16,500 shares of common stock through a restricted stock unit award.

Director Scott Smith acquired 16,500 shares of BioAtla, Inc. common stock through a restricted stock unit award.

Director Lawrence Steinman reports acquisition of 16,500 shares of BioAtla, Inc. common stock via restricted stock units.

Director Eddie Williams acquired 16,500 shares of BioAtla, Inc. common stock on June 13, 2024, through a restricted stock unit award.

Director Susan Moran acquired 16,500 shares of BioAtla, Inc. common stock through a restricted stock unit award.

Director Scott Andrew Smith of BioAtla, Inc. [BCAB] sold 2,181 shares of common stock on May 31, 2024, to cover income tax obligations related to vesting of restricted stock units.

Eric Sievers, Chief Medical Officer of BioAtla, Inc., reports a transaction involving the withholding of shares by the issuer to cover income tax obligations related to vesting restricted stock units.

Eric Sievers, Chief Medical Officer of BioAtla, Inc., reports a transaction involving the withholding of shares by the issuer to cover income tax obligations related to vesting restricted stock units.

Director Scott Andrew Smith reports a transaction involving the withholding of BioAtla shares to cover income tax obligations related to vesting restricted stock units.

Director Scott Andrew Smith of BioAtla, Inc. [BCAB] sold shares to cover income tax obligations related to vesting restricted stock units.

Eric Sievers, Chief Medical Officer of BioAtla, Inc., reports a transaction involving the withholding of shares by the issuer to cover income tax obligations related to vesting restricted stock units.

Director Scott Andrew Smith reports withholding of shares by BioAtla to cover income tax obligations related to vesting of restricted stock units.

Eric Sievers, Chief Medical Officer of BioAtla, Inc., reports a transaction involving the withholding of shares by the issuer to cover income tax obligations related to vesting restricted stock units.